Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials

Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials

Bibliographic Details
Main Authors:	Luqmani, R, Bacon, P, Rasmussen, N, Jayne, D
Format:	Journal article
Published:	2001

Similar Items

Validation of the Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials.
by: Luqmani, R, et al.
Published: (2000)

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
by: Luqmani, R, et al.
Published: (1994)

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
by: Mukhtyar, C, et al.
Published: (2008)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
by: Luqmani, R, et al.
Published: (2009)

Modified Birmingham vasculitis activity score for Wegener's granulomatosis (BVAS/WG) - Construct validity.
by: Maiden, N, et al.
Published: (2000)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
by: Mukhtyar, C, et al.
Published: (2009)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
by: Suppiah, R, et al.
Published: (2011)

Modification and validation of the Birmingham Vasculitis Activity Score (version 3).
by: Mukhtyar, C, et al.
Published: (2009)

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
by: Suppiah, R, et al.
Published: (2011)

Using the Birmingham Vasculitis Activity Score as a Screening Tool in Patients with Suspected Vasculitis
by: Floris, A, et al.
Published: (2016)

Validation of the Birmingham Vasculitis Activity Score (Version 3)
by: Mukhtyar, C, et al.
Published: (2009)

OP0055 Using the Birmingham Vasculitis Activity Score as a screening tool in patients with suspected vasculitis
by: Floris, A, et al.
Published: (2016)

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
by: Jayne, DR, et al.
Published: (1997)

Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides.
by: Demirkaya, E, et al.
Published: (2012)

European therapeutic trials in ANCA-associated systemic vasculitis: Disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl-Cr93-1078)
by: Rasmussen, N, et al.
Published: (1995)

The prognostic value of BVAS and VDI in ANCA-AAV
by: Suppiah, R, et al.
Published: (2011)

A multi-centre randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (Cycazarem).
by: Luqmani, R, et al.
Published: (1999)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
by: Suppiah, R, et al.
Published: (2011)

Validation of a new version of the Birmingbam vasculitis activity score
by: Mukhtyar, C, et al.
Published: (2008)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
by: Suppiah, R, et al.
Published: (2011)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
by: Luqmani, R, et al.
Published: (2007)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
by: Yew, S, et al.
Published: (2012)

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.
by: Bacon, P, et al.
Published: (1995)

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).
by: Stone, J, et al.
Published: (2001)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
by: Hellmich, B, et al.
Published: (2007)

THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
by: Yew, S, et al.
Published: (2012)

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
by: Mukhtyar, C, et al.
Published: (2007)

Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis
by: Hellmich, B, et al.
Published: (2006)

Development of comprehensive disease assessment in systemic vasculitis.
by: Flossmann, O, et al.
Published: (2007)

Development of comprehensive disease assessment in systemic vasculitis.
by: Flossmann, O, et al.
Published: (2008)

Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS)
by: Nakagomi, D, et al.
Published: (2017)

Disease activity assessment in childhood vasculitis: Development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)
by: Dolezalova, P, et al.
Published: (2013)

Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).
by: Dolezalova, P, et al.
Published: (2013)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
by: De Groot, K, et al.
Published: (2005)

Vasculitis integrated total assessment log (VITAL): A system for clinical evaluation of vasculitis.
by: Luqmani, R, et al.
Published: (1996)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in "non-renal" AbCA-associated vasculitis.
by: de Groot, K, et al.
Published: (2003)

Pulse versus daily oral CyP for induction of remission in ANCA-associated vasculitis. A European, multi-centre randomized controlled trial: long-term follow-up
by: Harper, L, et al.
Published: (2011)

Diagnosis and management of ANCA associated vasculitis.
by: Berden, A, et al.
Published: (2012)

Clinical features and structured clinical evaluation of vasculitis
by: Ponte, C, et al.
Published: (2018)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
by: Robson, J, et al.
Published: (2013)